CXCL8 can also act in concert with CCL20 to synergistically induce epithelial-mesenchymal transition (EMT) through the PI3K/AKT-ERK1/2 signaling axis, thereby promoting CRC metastasis progression (42). The gene discussed is CCL20; the disease is colorectal carcinoma.